3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Leukemia, Myeloid, Acute
17
Myelodysplastic Syndromes
12
Recurrence
7
Ovarian Neoplasms
7
Multiple Myeloma
7
Lymphoma
7
Burkitt Lymphoma
7
Pancreatic Neoplasms
6
Lymphoma, Non-Hodgkin
6
Lymphoma, B-Cell
6
Hodgkin Disease
5
Colorectal Neoplasms
5
Stomach Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Leukemia, Biphenotypic, Acute
4
Leukemia
4
Hematologic Neoplasms
4
Sarcoma
3
Osteosarcoma
3
Myeloproliferative Disorders
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia, B-Cell
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urogenital Neoplasms
2
Triple Negative Breast Neoplasms
2
Interventions
Bevacizumab
3
repotrectinib
1
durvalumab
1
atezolizumab
1
Tretinoin
1
Oviposition
1
Leucovorin
1
Irinotecan
1
Immunotherapy
1
Imatinib Mesylate
1
Fluorouracil
1
Drug Therapy
1
Drainage
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Digestive System Neoplasms
×
fludarabine
×
30 days
×
Clear all
No trials found.